v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenues
General and administrative costs:        
Compensation to related parties, including stock-based compensation expense of $106,827 and $112,106 for the three months ended September 30, 2024 and 2023, respectively, and $340,445 and $669,146 for the nine months ended September 30, 2024 and 2023, respectively 283,053 356,001 907,069 1,398,042
Patent and licensing legal and filing fees and costs 45,416 178,012 192,239 835,362
Other costs and expenses 293,158 357,681 1,168,582 1,081,893
Research and development costs, including $76,278 and $51,568 for the three months ended September 30, 2024 and 2023, respectively, and $210,362 and $156,950 for the nine months ended September 30, 2024 and 2023, respectively, to a related party 361,630 132,487 691,402 749,029
Total costs and expenses 983,257 1,024,181 2,959,292 4,064,326
Loss from operations (983,257) (1,024,181) (2,959,292) (4,064,326)
Interest income 1,437 5,809 6,529 13,538
Interest expense (1,049) (279) (12,389) (6,088)
Foreign currency gain (loss) (3,161) (109) (3,119) 2,102
Net loss $ (986,030) $ (1,018,760) $ (2,968,271) $ (4,054,774)
Net loss per common share basic $ (0.44) $ (0.49) $ (1.32) $ (2.25)
Net loss per common share diluted $ (0.44) $ (0.49) $ (1.32) $ (2.25)
Weighted average common shares outstanding basic 2,249,290 2,074,938 2,249,290 1,803,466
Weighted average common shares outstanding diluted 2,249,290 2,074,938 2,249,290 1,803,466

Source